Companion Animal Medicine Market Key Players Analysis - Merck & Co., Inc.; Ceva; Vetoquinol S.A.; Zoetis; Boehringer Ingelheim International GmbH.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook And Industry Analysis 2034"

The global Companion Animal Medicine market is estimated to reach over USD 54.5 billion by the year 2034, exhibiting a CAGR of 9.5% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1685

The COVID-19 pandemic had a notable impact on the animal healthcare sector, resulting in increased costs for veterinary services and diagnostic testing. Several countries experienced significant disruptions in supply chains and shortages of veterinary pharmaceuticals, largely due to temporary export restrictions, manufacturing shutdowns, and increased demand for medications redirected toward human healthcare needs. In response to the evolving situation, organizations such as the Centers for Disease Control and Prevention (CDC) issued specific guidelines in July 2020 to assist veterinarians in managing the care of companion animals during the health crisis.

Despite these challenges, the animal healthcare market is witnessing positive growth, largely supported by increased investments in research and development aimed at advancing innovative products. A key example includes Merck Animal Health's investment of USD 100 million in July 2021 to expand its manufacturing facility in Kansas, with a focus on enhancing the production capacity for animal vaccines.

In parallel, the growing rate of pet ownership has accelerated demand for smart monitoring and tracking technologies designed to improve pet health and welfare. Notable developments include Tractive's January 2022 launch of an LTE-enabled GPS tracker specifically designed for cats, and Petlibro's introduction of the Granary Series in June 2022, which features a 5-liter camera-enabled automated pet feeder. These advancements are expected to fuel demand for pet monitoring solutions, thereby contributing to the continued expansion of the animal healthcare market.

List of Prominent Players in the Companion Animal Medicine Market:
• Ashish Life Sciences Pvt Ltd (India)
• Bimeda, Inc.
• Biogénesis Bagó (US)
• Boehringer Ingelheim International GmbH.
• Brilliant Bio Pharma (India)
• Calier
• Ceva Sante Animale (France)
• Chanelle Pharma (Ireland)
• Dechra Pharmaceuticals PLC (UK)
• Eco Animal Health Group Plc. (UK)
• Elanco Animal Health Incorporated (US)
• Endovac Animal Health (US)
• HIPRA (Spain)
• Indian Immunologicals Ltd (India)
• Intas Pharmaceuticals (India)
• Kyoritsu Seiyaku (Japan)
• Lutim Pharma Pvt Ltd (India)
• Merck & Co., Inc.
• Neogen Corporation (US)
• Norbrook Holdings Limited (UK)
• Orion Group (Finland)
• Tianjin Ringpu Bio-Technology Co Ltd. (China)
• Vetindia Pharmaceuticals limited (India)
• Vetoquinol S.A.;
• Virbac
• Zenex Animal Health India Private Limited (India)
• Zoetis, Inc. (US)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The COVID-19 pandemic, coupled with the widespread adoption of remote work models, has contributed to a notable increase in pet ownership, largely driven by growing concerns related to mental health, including anxiety and depression. As reported in the European Pet Food Industry: Facts and Figures 2022, Germany recorded the adoption of approximately 10.3 million dogs and 16.7 million cats in 2021. During the same year, 21% of German households owned at least one cat, while 19% owned at least one dog, reflecting a higher preference for feline companionship. This trend underscores the rising societal inclination toward pet ownership as a means of emotional support and stress relief.

Challenges:
Despite ongoing efforts to enhance vaccination coverage among companion animals, uptake remains insufficient due to limited awareness, poor surveillance infrastructure, and gaps in reporting mechanisms. The absence of comprehensive, real-time data complicates strategic vaccine distribution and impedes timely responses to disease outbreaks. In many regions, underdeveloped monitoring systems lead to delays in diagnosis and disease reporting. Additionally, financial barriers further constrain progress, as many pet owners are reluctant to incur costs for diagnostic procedures, surveillance, and preventive healthcare. Although advancements in these systems are anticipated to mitigate zoonotic disease prevalence and improve public health outcomes, widespread adoption of companion animal vaccination will likely remain constrained without substantial investment in awareness and infrastructure.

Regional Trends:
North America is projected to lead the companion animal healthcare market over the forecast period, supported by increasing rates of pet ownership, heightened awareness regarding animal health, and the presence of prominent market players. Growth in the region is further fueled by higher spending on pet healthcare and a rising pet population. According to the American Pet Products Association (APPA) National Pet Owners Survey 2021-2022, approximately 70% of U.S. households-equivalent to 90.5 million homes-own pets. During the 2019-2020 period, an estimated 69 million households owned dogs, while 45.3 million owned cats. These figures reflect strong and sustained demand for veterinary services and companion animal healthcare solutions in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1685

Recent Developments:
• In January 2022, For the treatment of clinical manifestations of pruritus associated with allergic dermatitis in dogs and the treatment of clinical manifestations of atopic dermatitis in dogs that are at least 12 months old, Zoetis has been granted marketing authorization by the European Commission (EC) for Apoquel chewable tablets (oclacitinib).

Segmentation of Companion Animal Medicine Market-
By Animal Type-
• Dogs
• Cats
• Horses
• Others
By Product-
• Biologics
o Vaccines
 Attenuated Live Vaccines
 Inactivated Vaccines
 Recombinant Vaccines
 Toxoid
 Others
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
• Medicated Feed Additives
By Indication-
• Infectious Diseases
• Dermatologic Diseases
• Pain
• Orthopedic Diseases
• Behavioral Diseases
• Other Indications
By Distribution Channel-
• Retail
• E-commerce
• Hospital Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/companion-animal-medicine-market/1685

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.